31 March 2016 - The TGA has published an AusPAR today for two new medicines. An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

The AusPARs are for enzalutamide (Xtandi) and liraglutide (Saxenda).

For more details, go to: http://www.tga.gov.au/australian-public-assessment-reports-prescription-medicines-auspars